Loading…
Quest Diagnostics has signed a definitive agreement to acquire Cleveland HeartLab from equity investors including Cleveland Clinic. The transaction is expected to close in Q4 2017.
“Quest Diagnostics (NYSE: DGX) today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease.”newsroom.questdiagnostics.com
Summarized from public sources; check the original articles before acting on it.